Cargando…
Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma
Background: A growing number of clinical studies have confirmed that mRNA vaccines are effective in the treatment of malignant tumors; however, their efficacy in head and neck squamous cell carcinoma (HNSCC) has not been determined. This study aimed to identify the potential antigens of HNSCC for mR...
Autores principales: | Li, Hong-Xia, Liu, Tian-Run, Tu, Zhao-Xu, Xie, Chu-Bo, Wen, Wei-Ping, Sun, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855883/ https://www.ncbi.nlm.nih.gov/pubmed/36671475 http://dx.doi.org/10.3390/biom13010090 |
Ejemplares similares
-
Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
por: Chen, Yan, et al.
Publicado: (2022) -
Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development
por: Lu, Tong, et al.
Publicado: (2022) -
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma
por: Tian, Saisai, et al.
Publicado: (2018) -
Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022) -
A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)